Clinical trial
A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart…
NCT00098007 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00098007 |
|---|---|
| Title | A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients |
| Official title | Six-month, Multicenter, Randomized, Open-label Study of the Safety, Tolerability and Efficacy of Two Neoral Doses in Addition to Certican and Steroids in de Novo Heart Transplant Recipients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Transplantation |
| Intervention type | Drug |
| Interventions | Everolimus (Certican) |
| Enrollment | 199 |
| Start date | Aug 9, 2004 |
| Primary completion | Jan 8, 2007 |
| Completion | Jan 8, 2007 |
| First posted | Dec 2, 2004 |
| Last update posted | Feb 23, 2017 |
| Countries | Australia, Austria, Brazil, Canada, Germany, Italy, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: